Evidence map›Paper›PMID 38481069›Full record

ReviewSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Skin boosters: Definitions and varied classifications.

Kyu-Ho Yi, Waranaree Winayanuwattikun, Sung-Yeon Kim, Jovian Wan, Vanravi Vachatimanont, Ardhiah Iswanda Putri, Inneke Jane Hidajat, Yuri Yogya, Ruri Pamela

RetractedOpen access · hybridAbstract readReviewRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Review in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 4 countries.

Kyu-Ho YiDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
Waranaree WinayanuwattikunDivision of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Sung-Yeon KimVS Line Clinic, Incheon, South Korea.
Jovian WanAsia-Pacific Aesthetic Academy, Honk Kong, Hong Kong.
Vanravi VachatimanontiSKY Center, Bangkok, Thailand.
Ardhiah Iswanda PutriRejuva Clinic, Surabaya, Indonesia.
Inneke Jane HidajatDepartment of Dermatology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Yuri YogyaDepartment of Dermatology and Venereology, Universitas Padjadjaran, Bandung, Indonesia.
Ruri PamelaCELV Dermatology Clinic, Jakarta, Indonesia.
ASM Pacific Technology (China) · CNAtma Jaya Catholic University of Indonesia · IDBangkok University · THIncheon Medical Center · KRMahidol University · THPadjadjaran University · IDSunlin University · KRUniversity of Surabaya · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe concept of "skin boosters" has evolved, marking a shift from traditional uses of hyaluronic acid (HA) fillers primarily for augmenting skin volume to a more diverse application aimed at improving dermal conditions. Restylane Vital and other HA fillers have been repurposed to combat skin aging and wrinkles by delivering HA directly to the dermis.

objectivesThis review aims to define the term "skin booster" and to discuss the various components that constitute skin boosters. It seeks to provide a comprehensive overview of the different ingredients used in skin boosters, their roles, and their impact on enhancing dermal conditions.

methodsA comprehensive review was conducted, focusing on representative skin booster ingredients. The approach involved analyzing the different elements used in skin boosters and their specific roles in enhancing dermal improvement.

resultsThe findings indicate that skin boosters, encompassing a range of ingredients, are effective in improving the condition of the skin's dermis. The review identifies key ingredients in skin boosters and their specific benefits, including hydration, elasticity improvement, and wrinkle reduction.

conclusionsSkin boosters represent a significant development in dermatological treatments, offering diverse benefits beyond traditional HA fillers. This review provides valuable insights into the constituents of skin boosters and their effectiveness, aiding readers in making informed decisions about these treatments. The potential of skin boosters in dermatological practice is considerable, warranting further research and application.

Indexed as

Cosmetic TechniquesDermal FillersSkin AgingHumansHyaluronic AcidRejuvenationSkinDermal FillersHyaluronic Acidbotulinum neurotoxinexosomegrowth factorhyaluronic acid fillerpolydeoxyribonucleotidepoly-D-lactic acidpoly-L-lactic acidpolynucleotidessecretomeskin booster

Identifiers

PMID38481069
PMCPMC10938033
OpenAlexW4392813780

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.